Related Experiment Video
Updated: Nov 24, 2025

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
Olfactory function and findings on chest computed tomography in COVID-19: is there any correlation?
Lucas Resende Lucinda Mangia1, Marcelly Botelho Soares1, Thiago Sasso Carmona de Souza1
1Department of Otolaryngology - Head and Neck Surgery, Universidade Federal do Paraná (HC-UFPR), Curitiba, Brazil.
Olfactory dysfunction in COVID-19 patients does not correlate with lung involvement seen on CT scans. This suggests distinct underlying mechanisms for smell loss and pulmonary disease in COVID-19.
Area of Science:
- Infectious Diseases
- Pulmonology
- Neurology
Background:
- Olfactory dysfunction is common in COVID-19, often co-occurring with pulmonary issues.
- The relationship between olfactory function and lung involvement in COVID-19 requires further clinical investigation.
- Distinct pathophysiological mechanisms may underlie these co-manifestations.
Purpose of the Study:
- To investigate the correlation between olfactory function and radiological pulmonary involvement in hospitalized COVID-19 patients.
- To determine if olfactory dysfunction severity aligns with the extent of lung damage in COVID-19.
Main Methods:
- Consecutive recruitment of hospitalized severe COVID-19 patients.
- Objective olfactory function (OF) assessment using the Alcohol Sniff Test.
- Chest computed tomography (cCT) for qualitative and quantitative lung involvement analysis (CT severity score).
Main Results:
- No statistically significant correlation was found between olfactory function and the grade of lung involvement (p=0.884).
- No correlation was observed between olfactory function and the CT severity score (Pearson's r=-0.111).
- Patients with COVID-19-typical radiological findings showed no significant difference in OF compared to others (p=0.193).
Conclusions:
- Olfactory dysfunction is not associated with the degree of radiological lung involvement in hospitalized COVID-19 patients.
- Clinical evidence supports that olfactory disorders and pulmonary disease in COVID-19 operate via separate mechanisms.
- This finding aids in understanding the multifaceted nature of COVID-19's impact on different organ systems.
More Related Videos
Related Concept Videos
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Radiological Investigation III: Pulmonary Angiogram and PET Scan
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Respiratory System Abnormal Finding II: Palpation and Auscultation
Palpation Findings
During a respiratory assessment, palpation can reveal several vital abnormalities:
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Respiratory System Abnormal Finding I: Inspection and Percussion
Inspection Findings
During an inspection, several findings may suggest the presence of respiratory distress or disease. Pursed-lip breathing, where exhalation is slowed by...
Olfaction
The olfactory receptors are embedded in the cilia of the...

